Gemini BIO-products (BPA) *** shannon skarshaug *** 10/4B50 * P#301-435-3711 *** quote# 0343506 *** pots 14-026404

Ended Awarded

Contract number
HHSN26100019
Awardee
Awarding agency
Obligated
$9,000

Award facts

Contract value 33% obligated
  • $9,000.00 Current, with exercised options
  • $27,000.00 Potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
621511 Medical Laboratories
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Broderick, CA 95605, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The National Cancer Institute awarded a $27,000 firm fixed-price Blanket Purchase Agreement (BPA) call to Gemini Bioproducts LLC on March 28, 2014, with a completion date of May 31, 2014. This contract, which received no set-aside designation, is associated with a larger $100 million single-award BPA vehicle managed by the Office of Logistics and Acquisition Operations. The award was made to the West Sacramento, California-based vendor under Quote #0343506 and represents a call against the existing blanket purchase agreement for the procurement of cell culture products, sera, reagents, and related scientific supplies used in biomedical research.

Gemini Bioproducts LLC specializes in manufacturing and supplying high-quality cell culture media, fetal bovine serum, and specialized biological reagents critical to federal research institutions. The company, registered in SAM.gov since 2001, has established a strong track record as a key supplier to the National Institutes of Health and its constituent institutes, including the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Heart Lung and Blood Institute. This BPA call reflects the company's strategic importance in supporting the federal government's biomedical research mission through reliable delivery of essential laboratory and research materials.

Quick answers

Who was awarded contract HHSN26100019?

HHSN26100019 was awarded to Gemini Bioproducts LLC by National Cancer Institute (National Institutes of Health) on March 28, 2014.

How much is contract HHSN26100019 worth?

The government has obligated $9,000 on HHSN26100019. Its potential value, with all options, is $27,000.

Is contract HHSN26100019 an order under another contract?

Yes. HHSN26100019 is a BPA call under HHSN263199700048255B, a blanket purchase agreement.

Was contract HHSN26100019 competed?

The extent of competition for HHSN26100019 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login